Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,504
Total Claims
$429K
Drug Cost
514
Beneficiaries
$834
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+25%
Opioid rate vs peers
3.2% vs 2.6% avg
-22%
Cost per patient vs peers
$834 vs $1,068 avg
+9%
Brand preference vs peers
9.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.2%
Opioid Rate
178
Opioid Claims
$2,065
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 531 claims · $335K
Generic: 4,899 claims · $91K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 52 | $61K |
| Tirzepatide | 17 | $24K |
| Semaglutide | 11 | $21K |
| Insulin Degludec | 11 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 20 | $14K |
| Insulin Lispro | 11 | $6,347 |
| Atorvastatin Calcium | 334 | $4,131 |
| Gabapentin | 125 | $4,024 |
| Levothyroxine Sodium | 314 | $4,000 |
| Losartan Potassium | 292 | $3,349 |
| Tamsulosin Hcl | 141 | $2,616 |
| Levothyroxine Sodium | 32 | $2,607 |
| Metoprolol Succinate | 170 | $2,586 |
| Icosapent Ethyl | 13 | $2,517 |
| Pantoprazole Sodium | 91 | $2,220 |
Prescribing Profile
Patient Profile
75
Avg Age
48%
Female
1.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About